#IL17

Recent research led by MIT and Harvard Medical School has uncovered the intriguing role that the immune molecule interleukin-17 (IL-17) plays in shaping social behavior and anxiety by acting directly on specific brain regions. This groundbreaking study reveals that IL-17 serves dual functions: enhancing sociability by reducing neuron excitability in the brain’s cortex and triggering anxiety by increasing excitability in the amygdala. These findings suggest IL-17 acts like a neuromodulator, drawing a fascinating link between immune system activity and behavioral outcomes, with potential implications for the treatment of conditions like autism and depression (Neuroscience News).